Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents

Xue Gao,Yong Tao,Veronica Lamas,Mingqian Huang,Wei-Hsi Yeh,Bifeng Pan,Yu-Juan Hu,Johnny H. Hu,David B. Thompson,Yilai Shu,Yamin Li,Hongyang Wang,Shiming Yang,Qiaobing Xu,Daniel B. Polley,M. Charles Liberman,Wei-Jia Kong,Jeffrey R. Holt,Zheng-Yi Chen,David R. Liu
DOI: https://doi.org/10.1038/nature25164
IF: 64.8
2017-12-20
Nature
Abstract:CRISPR–Cas9 genome editing is used to correct a dominant-negative mutation in a mouse model of inherited deafness, resulting in improvements in cochlear function and hearing.
multidisciplinary sciences
What problem does this paper attempt to address?